Gault Cheryl
Rapport Therapeutics, Inc. Common Stock · Chief Operating Officer
Gault Cheryl is listed in filings as Chief Operating Officer at Rapport Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Mar 31, 2026, including sale activity. Recent filings connect the profile to Rapport Therapeutics, Inc. Common Stock (RAPP). The current snapshot covers public activity from Feb 4, 2025 to Mar 31, 2026. Reported amounts are shown as $2.1M to $9.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $81k2.8k shares | SellMar 30, 2026 | $28.55 | $40.13 | |
| $201k7.2k shares | SellMar 30, 2026 | $28.04 | $40.13 |